Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIf you have a contraceptive implant and are starting Mounjaro (tirzepatide) for weight management, the straightforward answer is reassuring: unlike oral contraceptive pills, the implant is not absorbed through the gut, so Mounjaro's effect on gastric emptying is very unlikely to reduce its contraceptive effectiveness. That said, the picture is not entirely without nuance, and a prescriber should always review your full contraceptive situation before treatment begins. Mounjaro is a prescription-only medicine — suitability is determined by a clinician after a personal assessment, not by a checklist.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Mounjaro slows the rate at which food and liquid move through the stomach. For medicines taken by mouth, that delay can change how much of the active ingredient gets absorbed into the bloodstream. Oral contraceptive pills depend on gut absorption, which is exactly why NHS guidance recommends adding a non-oral method (such as condoms) during the first four weeks of tirzepatide and after each dose increase, if you rely on the combined or progestogen-only pill. You can read the full detail of that recommendation on our page about Mounjaro and the contraceptive pill.
The contraceptive implant works on a completely different principle. A small flexible rod is inserted under the skin of the upper arm, where it slowly releases progestogen directly into your bloodstream. There is no tablet to dissolve, no gut absorption required. The implant's effectiveness therefore does not depend on how quickly your stomach empties, which is the mechanism of concern with the pill. If you want to understand in more detail whether Mounjaro affects the contraceptive pill and why that concern arises, we cover the pharmacology fully on a dedicated page. On the basis of current pharmacology, the MHRA and NHS guidance does not identify the implant as requiring additional cover when starting tirzepatide. NHS England's weight-management injections guidance sets out the contraception precautions in full, and they are specifically directed at oral methods.
That distinction is meaningful. It is not a gap in the guidance, it reflects a genuine pharmacological difference in how these two methods work. If you have recently switched from the pill to the implant, or use both, do tell your prescriber; they will confirm exactly where you stand.
Based on current evidence and UK prescribing guidance, having a contraceptive implant in place is not a reason to withhold Mounjaro. The MHRA-approved summary of product characteristics for tirzepatide does not list the implant among contraindications or interactions requiring dose adjustment. The NHS tirzepatide medicines page advises women of childbearing potential to use effective contraception, the implant, when in date and correctly placed, is considered highly effective under UK guidance.
We do want to be honest about what is uncertain, because that matters here. There is no large clinical trial specifically studying tirzepatide alongside the contraceptive implant. The reassurance is grounded in mechanism (gut absorption is not in the picture) rather than in a dedicated head-to-head study. For the vast majority of people with an implant, the pharmacological reasoning is solid, but it cannot substitute for a personalised clinical conversation. If you have any condition affecting hormone metabolism, or if your implant is nearing its replacement date, your prescriber needs to know.
It is also worth noting that significant weight loss itself can sometimes prompt changes in how hormones behave in the body. That is not a reason to avoid treatment, but it is one more thing worth mentioning when you speak to a clinician. Our overview of Mounjaro and contraception covers the broader context for people on different methods.
There is a reasonable chance you are reading this because you want to feel certain before committing, that is a sensible instinct, not an over-reaction. The right step is a conversation with a prescriber before your first dose, not after.
At the consultation stage, tell the prescriber you have a contraceptive implant: when it was fitted, when it is due for replacement, and whether you are using any other hormonal or non-hormonal contraception alongside it. If you are planning to try to conceive in the near future, that changes the picture significantly, Mounjaro is not recommended during pregnancy, or when actively trying to conceive, and your prescriber will advise on the appropriate wash-out period in line with MHRA guidance.
If you are already on Mounjaro and have questions about switching contraceptive methods, speak to your GP or sexual health clinic as well as your prescribing team. The same applies if your implant needs replacing while you are mid-treatment. For questions specific to your treatment with us, our aftercare team is available seven days a week. You might also find it helpful to read about Mounjaro and oral contraceptives if you are considering switching methods, or to visit our Mounjaro overview for a fuller picture of how the treatment works. If you are weighing up your options around using Mounjaro alongside the contraception pill, that page brings together the key guidance in one place. If you are ready to take the next step, you can speak to our prescribers through a free consultation, reviewed the same day by a GPhC-registered Independent Prescriber.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.